Rxi Pharmaceuticals Corporation Warrants Expirin (RXIIW)
Rxi Pharmaceuticals Corporation Warrants Expirin (RXIIW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXIIW | ||||
| Company | Rxi Pharmaceuticals Corporation Warrants Expirin | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 0.05 | ||||
| High | 0.10 | ||||
| Low | 0.05 | ||||
| Latest | 0.06 | ||||
| Change | -0.06 | ||||
| % Change | -50.00% | ||||
| Volume | 15,000 | ||||
| 20-Day Average Volume | 1,840 | ||||
| Previous Close | 0.12 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 0.28 | ||||
| 20-Day Raw Stochastic | 1.89% | ||||
| 20-Day Relative Strength | 38.86 | ||||
| Weighted Alpha | -90.46 | ||||
| Today's Opinion | N/A | ||||
| Previous Opinion | N/A | ||||
| Last Month's Opinion | N/A | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -50.00% since 10/30/18 | ||||
| Low | 0.05 on 11/16/18 | ||||
| High | 0.10 on 11/16/18 | ||||
| 1-Month | |||||
| %Chg | -50.00% since 10/16/18 | ||||
| Low | 0.05 on 11/16/18 | ||||
| High | 0.12 on 10/30/18 | ||||
| 3-Month | |||||
| %Chg | -88.89% since 08/13/18 | ||||
| Low | 0.05 on 11/16/18 | ||||
| High | 0.50 on 08/27/18 | ||||
| 6-Month | |||||
| %Chg | -85.00% since 05/14/18 | ||||
| Low | 0.05 on 11/16/18 | ||||
| High | 0.58 on 07/16/18 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 0 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||